← Back to all trials
Active Not Recruiting
NCT04931329
Onco-haematology Vigilance Card
Conditions: Medical Oncology, Hematology, Molecular Targeted Therapies
Sex: All
Enrollment: 100
Sponsor: University Hospital, Limoges
Location: CHU de Limoges Limoges
Summary
The objective of this study is to show the interest of setting up a drug vigilance card in Oncology in order to reinforce patient safety, develop compliance and avoid drug interactions when the patient consults town professionals or other specialists.
Eligibility Criteria
Inclusion Criteria:
* All patients treated at Limoges University Hospital in Medical Oncology department, receiving oral treatment (chemotherapy and/or targeted therapies)
Exclusion Criteria:
* All patients treated at Limoges University Hospital in Medical Oncology department, receiving hormone therapy or IV treatment only.
Source: ClinicalTrials.gov (NCT04931329). StuddyBuddy aggregates publicly available trial information.
